SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of November 2020. The filing serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The registrant's principal executive offices are located in Beijing, People's Republic of China. The filing was signed by Zhang Rui (Kerrie), Chief Financial Officer, on November 6, 2020.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not disclose any material changes in financial condition or operations compared to prior periods. The document primarily consists of the cover page, exhibit index, and signature block.
Guidance, Outlook, and Risks
The filing does not include management commentary, forward-looking guidance, risk factors, or contingencies. The content is limited to the submission of exhibits, which include a Press Release (Exhibit 99.1), a Notice of the Annual General Meeting and Proxy Statement (Exhibit 99.2), and a Proxy Card (Exhibit 99.3).
Key Facts for Investor Verification
- The filing is a procedural Form 6-K for November 2020 and does not contain embedded financial statements.
- Investors must review the attached exhibits (specifically Exhibit 99.1 and 99.2) to obtain details on the press release and the Annual General Meeting.
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.
- The filing confirms the company files annual reports under Form 20-F.